Entera Bio Ltd. (ENTX) vs Tenaya Therapeutics, Inc. (TNYA)
A side-by-side comparison of Entera Bio Ltd. and Tenaya Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.53HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNYA
Tenaya Therapeutics, Inc.
$0.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ENTX vs TNYA
growth of $100 · dividends reinvested · last 5yENTX -49.0% (-12.6%/yr)TNYA -96.3% (-48.4%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
ENTX TNYA
ENTX vs TNYA: by the numbers
- •ENTX is the larger company ($125M vs $119M market cap).
- •Both run net losses; TNYA's is the smaller (-7723.97% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENTX | TNYA |
|---|---|---|
| P/S ratio | N/A | 88.83 |
| P/B ratio | 17.16 | 1.71 |
Profitability
| Metric | ENTX | TNYA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | -27450.00% | 0.00% |
| Net margin | -27235.71% | -7723.97% |
| ROE | -234.42% | -148.56% |
| ROIC | -82.87% | -142.06% |
Growth (annualized)
| Metric | ENTX | TNYA |
|---|---|---|
| Total return CAGR (5Y) | -10.57% | -52.81% |
Frequently asked
- How have ENTX and TNYA total returns compared?
- Over the past 5 years, ENTX delivered -10.57% and TNYA delivered -52.81% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.